Navigation Links
Researchers Use Magnetism to Target Cells to Animal Arteries
Date:1/7/2008

- Magnetically Guided Nanoparticles May Deliver Treatments to Human Organs -

PHILADELPHIA, Jan. 7 /PRNewswire-USNewswire/ -- Scientists have used magnetic fields and tiny iron-bearing particles to drive healthy cells to targeted sites in blood vessels. The research, done in animals, may lead to a new method of delivering cells and genes to repair injured or diseased organs in people.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080107/DC10966 )

The study team, led by Robert J. Levy, M.D., the William J. Rashkind Chair of Pediatric Cardiology at The Children's Hospital of Philadelphia, loaded endothelial cells, flat cells that line the inside of blood vessels, with nanoparticles, tiny spheres nanometers in diameter. The nanoparticles contained iron oxide.

Using an external, uniform magnetic field, Levy's team directed the cells into steel stents, small metal scaffolds that had been inserted into the carotid arteries of rats. The uniform magnetic field created "magnetic gradients," local regions of high magnetic force that magnetized both the nanoparticles and the stents, thus increasing the attraction between the particles and their target.

The study appears in the Proceedings of the National Academy of Sciences, published online on Jan. 7. Dr. Levy's group from Children's Hospital collaborated with engineers from Drexel University and Duke University.

"This is a novel strategy for delivering cells to targets in the body," said Levy, who added that previous researchers have pursued other, less successful approaches to introduce endothelial cells to diseased blood vessels, in the developing medical field of cell therapy.

Levy's team created nanoparticles, approximately 290 nanometers across, made of the biodegradable polymer, polylactic acid, and impregnated with iron oxide. (A nanometer is a millionth of a millimeter;
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novel Mechanism for Long-Term Learning Identified by Carnegie Mellon Researchers
2. Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models
3. Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos
4. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
5. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
6. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
7. U. of Md. Researchers to Develop Devices to Revolutionize Drug Research
8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
9. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Availity Teams with Thomson Reuters to Integrate Treatment Cost Calculator 47491 1Availity Teams with Thomson Reuters to Integrate Treatment Cost Calculator 47491 2Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs 47488 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 2Findings in epilepsy gene in animals may guide treatment directions for infants 47484 3